Guardian Pharmacy Services (GRDN) Common Equity (2023 - 2026)

Guardian Pharmacy Services (GRDN) has 4 years of Common Equity data on file, last reported at $232.4 million in Q1 2026.

• Quarterly Common Equity rose 42.4% year-over-year to $232.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $232.4 million (up 42.4% YoY) and the FY2025 annual result came in at $217.9 million, up 45.31% from the prior year.
• Common Equity advanced to $232.4 million in Q1 2026 per GRDN's latest filing, from $217.9 million in the prior quarter.
• The five-year high for Common Equity was $232.4 million in Q1 2026, with the low at $56.6 million in Q1 2024.
• Average Common Equity over 4 years is $136.9 million, with a median of $150.0 million recorded in 2024.
• Year-over-year, Common Equity surged 214.04% in 2025 and soared 42.4% in 2026.
• Guardian Pharmacy Services' Common Equity stood at $59.9 million in 2023, then surged by 150.55% to $150.0 million in 2024, then soared by 45.31% to $217.9 million in 2025, then rose by 6.65% to $232.4 million in 2026.
• Business Quant data shows GRDN's Common Equity at $232.4 million in Q1 2026, $217.9 million in Q4 2025, and $195.5 million in Q3 2025.